ArticleCytotechnology2022
Th22/IL-22 mediates the progression of HBV-related hepatocellular carcinoma via STAT3.
Jia Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleCytotechnology2022
Jia Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.